Anteo Diagnostics Ltd has released a press release.
R & D Refund Received
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- Rights Issue Raises $2.15 million
- Heads of Agreement signed with Merck
- Rights Commence Trading
- Rights Issue Prospectus
- AnteoTech Granted Key US Battery Patent
Later from AnteoTech
- AnteoTech and Axxin Build Successful Sepsis Multiplex Test
- AnteoTech Advances Battery Technology Program
- AnteoTech Developing Multiplex Test for COVID-19
- AnteoTech Secures $3.76M Option Underwriting Agreement
- Preliminary Final Report
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech